Anti-Inflammatory Effect of
the Embelia tsjeriam
-Cottam
Fruit Extracts.
Sambrekar Sudhir N.1* Patil P.A.2 and Suhas A. Patil1
1Dept
of Pharmacology, Maratha Mandal’s College of Pharmacy, Belgaum, India.
2Dept
of Pharmacology, K.L.E’s Institute of Dental Sciences Bangalore.India.
ABSTRACT:
Extracts of
Embelia tsjeriam-cottam Fruits were investigated for anti-inflammatory
activity with acute and chronic models. In the doses of 200 mg kg-1exhibited
significant (P < 0.001) anti-inflammatory activity in all the models
tested. The alcohol extract of Embelia tsjeriam-cottam at 200 mg kg-1
showed maximum inhibition of paw
volume 1.21 ± 0.1 in carrageenan-induced
rat paw edema while the standard drug Diclofenac it was 1.18 ± 0.1 after 6 hrs of carrageenan
injection. In the chronic inflammatory model alcoholic extract inhibited the
granuloma weight by 35.50 %, whereas the Diclofenac inhibited 46.18%.
KEYWORDS: Anti-inflammatory activity, carrageenan induced rat paw, cotton pellet
induced granuloma, Embelia tsjeriam-cottam
INTRODUCTION:
Inflammation
is a local response of living mammalian tissues to the injury. It is a body
defense reaction in order to eliminate or limit the spread of injurious agents.
There are various components to an inflammatory reaction that can contribute to
the associated symptoms and tissue injury. Edema formation, leukocyte
infiltration and granuloma formation represent such components of inflammation. Edema formation in the paw is
the result of a synergism between various inflammatory mediators that increase
vascular permeability and/or the mediators that increase blood flow. Several
experimental models of paw edema have been described. Carrageenan-induced paw
edema is widely used for determining the acute phase of inflammation.
Histamine, 5-hydroxytryptamine and
bradykinin are the first detectable mediators in the early phase of
carrageenan-induced inflammation whereas
prostaglandins are detectable in the late phase of inflammation. Drugs which
are in use presently for the management of pain and inflammatory conditions are
either narcotics e.g. opioids or non-narcotics e.g. salicylates and
corticosteroids e.g. hydrocortisone. All of these drugs possess well known side
and toxic effects. Moreover, synthetic drugs are very expensive to develop and
whose cost of development ranges from 0.5 to 5 million dollars. On the contrary
many medicines of plant origin had been used since long time without any
adverse effects. Exploring the healing power of plants is an ancient concept.
For centuries people have been trying to alleviate and treat disease with different
plant extracts and formulations. It is therefore essential that efforts should
be made to introduce new medicinal plants to develop cheaper drugs. Plants
represent still a large untapped source of structurally novel compounds that
might serve as lead for the development of novel drugs. Screening of the plants
for their biological activity is done on the basis of either their
chemotaxonomic investigation or ethnobotanical knowledge for a particular
disease.
Identification
of a particular compound against a specific disease is a challenging long
process. Importance of the plant lies in their biologically active principles.
There are two types of plant chemicals, primary metabolites such as sugars,
proteins, amino acids, chlorophylls etc. The other category of chemicals is
called secondary metabolites, which includes alkaloids, terpenoids, saponins
and phenolic compounds. These chemicals exert a significant physiological
effect on the mammalian system. A lot of references are available in the field
of ethnomedicinal plants used as anti-inflammatory drugs.
Embelia tsjeriam-cottam
is cultivated in India, Myanmar
and Sri lanka. In India it is common in the most forests of Karnataka, Kerala
and Tamilnadu. It is propagated
by seeds. Fruit contains embelin, quercitol, fatty ingredients and
vilangin. Fruits of Embelia tsjeriam used as appetizer; carminative, anthelmintic,
taenifuge, antispasmodic alexiteric, laxative, alterative; cures tumours,
ascites, bronchitis, mental diseases, dyspnoea, heart diseases, blood purifier,
fever, tonsil, urinary discharges, useed in snake-bite, stomach disorders,Anti-inflammatory, Jaundice,
hemicrania, wound, analgesic, purgative indolent ulcer of the mouth and the
gums. Sushruta describes the use of fruits along with liquorice root for the
purpose of strengthening the body and preventing the effect of age.1,2,3
Preparation of extract:
Embelia tsjeriam-cottam fruits collected from open field around Belgaum city in the month
of May - June were identified and authenticated by the taxonomist Dr. Harsha
Hegde and the herbarium (voucher no. RMRC-487) has been preserved at Regional
Medical Research Centre, Belgaum a unit of Indian council for medical research
New Delhi. Dried fruits were powdered to moderately coarse grade. Petroleum ether,
chloroform, alcohol and aqueous extracts of fruits were obtained by using
soxhlet extractor. The extraction was continued for 12 cycles or until the
solvent in the thimble was clears. After evaporating the solvent, the dark
brown semisolid extract was obtained .The phytochemical analysis was carried
out and further extract was kept in an air tight container at 4°C for future
use.
Phytochemical analysis:
The
extracts were subjected to phytochemical analysis for constituent
identification using standard protocol.4
Animals:
Female Wister rats 180-200 g of either sex
were used for Anti-inflammatory study and Swiss albino mice of either sex
weighing between 20-30 gms for acute toxicity study to determine LD50
of various extracts. Animals were procured from Venkateshwara Enterprises,
Bangalore. The animals were kept in the
standard polypropylene cages and provided with food and water ad libitum. The
animals were acclimatized for a period of 14 days prior to perform the
experiments. The experimental protocols were approved by Institutional Animal
Ethical Committee (Resolution No 1/2/2007, dated 23-11-2007).
Acute Oral Toxicity study:5
The acute oral toxicity study was carried
out as per the guidelines set by Organization for Economic Co–operation and
Development (OECD), received draft guidelines 425, received from Committee for
the Purpose of Control and Supervision of Experiments on Animals ( CPCSEA) , Ministry of Social Justice and
Empowerment, Government of India. Swiss
albino mice weighing between 20-30 gms were fasted over night prior to the
acute experimental procedure. The principle, which is based on a stepwise
procedure with the use of a minimum number of animals per step. The LD50
of different extracts were determined. The therapeutic dose was calculated
as1/10th of the lethal dose
for further investigation
Carrageenan induced rat paw edema:6
The rats
were divided into four groups, each group consisting of six animals. Edema was
induced by subplantar injection of 0.1% freshly prepared carrageenan suspension
into the right hind paw of each rat. The paw volume was measured at 1 h, 3 h
and at 6th hour after the injection of carrageenan, using a
plethysmometer.7 The
alcoholic and aqueous extract of Embelia tsjeriam-cottam
at 200 mg kg-1 doses were administered orally to first two groups of rats.
The third and fourth groups of rats received 5 ml kg-1 of 2% w/v Tween 80
orally as vehicle control and 50 mg kg-1 diclofenac as standard respectively,
for assessing comparative pharmacological significance. Drug pretreatment was
given 1 h before the injection of carrageenan.
Cotton pellet induced granuloma:8
The four
groups of rats, six in each group was included in this study. After shaving off
the fur the animals were anaesthetized. Sterile preweighed cotton pellets (50 ±
1 mg) were implanted in the axilla region of each rat through a single needle
incision.7 Alcoholic and aqueous
extract of Embelia
tsjeriam-cottam at a dose of
200 mg kg-1, diclofenac at 50 mg kg-1 (standard) and 5 ml kg-1 of 2%w/v Tween
80 (control) were administered orally to the respective group of animals for
seven consecutive days, from the day of cotton-pellet implantation. On the
eighth day, the animals were anaesthetized again; the cotton pellets were
removed surgically and made free from extraneous tissues. The pellets were
incubated at 37 °C for 24 h and dried at 60°C to constant weight. The increase
in the dry weight of the pellets was taken as a measure of granuloma formation.
Statistical
analysis:
Results are
expressed as Mean ± S.E.M. The difference between experimental groups was
compared by One-way Analysis of Variance (ANOVA) followed by Dunnett’s test.
The results were considered statistically significant when P < 0.05.
Table-1:
Phytochemical Screening of Embelia tsjeriam-cottam.
Extracts |
Steroid |
Carbo hydrate |
Alkaloides |
Saponin |
Tannin |
Flavonoid |
Alcohol |
+++ |
- |
++ |
+ |
+++ |
++ |
Aqueous |
- |
- |
+ |
- |
++ |
+ |
+++
= High concentration, ++ =
medium concentration, + = low concentration, - = absent.
Table-2:
Effect of fruit extract of Embelia tsjeriam-cottam on Carrageenan induced Rat Paw Edema.
|
Paw volume in ml (MEAN ± SEM) |
||||
Group |
Dose/kg b.w. |
0 hr |
1 hr |
3 hr |
6 hr |
Control |
1%Tween 80 1mlv/v |
1.28 ± 0.01 |
1.82 ± 0.01 |
1.91 ± 0.02 |
2.05 ± 0.01 |
Standard |
50 |
1.21 ± 0.01 |
1.68 ± 0.01*** |
1.28 ± 0.01*** |
1.18 ± 0.01*** |
Alcoholic Extract |
200 |
1.21 ± 0.01 |
1.59 ± 0.01*** |
1.33 ± 0.01*** |
1.21 ± 0.01*** |
Aqueous .Extract |
200 |
1.27 ± 0.01 |
1.70 ± 0.01** |
1.77 ± 0.01** |
1.52 ± 0.01** |
Standard=Diclofenac.
Each value
is the Mean ± S.E.M. for 6 rats . **=P < 0.01; ***P <0.001 compared with
control.
Table-3:
Effect of fruit extract of Embelia tsjeriam-cottam on Cotton Pellet-Induced
Granuloma in Rats.
GROUPS |
DOSE mg/kg |
WEIGHT OF COTTON PELLET-DRY(mg) |
% INHHIBITION |
Control |
Tween 80 1mlv/v |
55.00 ± 0.20 |
- |
Standard |
50 |
29.60 ± 0.35*** |
46.18 |
Alcoholic Extract |
200 |
35.47 ± 0.38*** |
35.50 |
Aqueous .Extract |
200 |
46.15 ± 0.25** |
16.09 |
Standard=diclofenac.
Each value is the Mean ± S.E.M. for 6 rats
**=P < 0.01; ***P < 0.001 compared with control
RESULTS:
The
phytochemical investigation results are given in Table-1. Phytochemical studies of various
extract showed presence of sterols, flavonoids, tannins and alkaloids.
The
activities of alcoholic and aqueous extracts of Embelia tsjeriam - cottam
against Carrageenan induced rat Paw Edema are given in Table-2. Both the
alcoholic and aqueous extracts administered orally (200mg/kg) showed
significant inhibitory effect against edema formation, 1, 3 and 6 hours after
carrageenan injection. The peak inhibitory effect of alcoholic extract of Embelia tsjeriam - cottam was comparable with Diclofenac treated group
(50mg/kg).
The results
of Cotton pellet induced granuloma test are given in Table-3 The Embelia tsjeriam - cottam showed similar significant (p<0.001)
inhibition of granuloma formation, comparable to that of Diclofenac.
In all the
above parameters used for the study aqueous extract also showed the
anti-inflammatory effect but it was less significant (p < 0.01) as compared
to alcoholic extract treated groups ( p <0.001).
DISCUSSION:
In spite of tremendous development in the field of
synthetic drugs during recent era, they are found to have some or other side
effects, whereas plants still hold their own unique place, by the way of having
no side effects. Therefore, a systematic approach should be made to find out
the efficacy of plants against inflammation so as to explore them as herbal
anti-inflammatory agents. The enzyme, phospholipase A2, is known to be
responsible for the formation of mediators of inflammation such as
prostaglandins and leukotrienes which by attracting polymerphonuclear
leucocytes to the site of inflammation would lead to tissue damage probably by
the release of free radicals. Phospholipase A2 converts phospholipids in the
cell membrane into arachidonic acid, which is highly reactive and is rapidly
metabolized by cyclooxygenase (prostaglandin synthesis) to prostaglandins,
which are major components that induce pain and inflammation.9,10
It is well known that carrageenan induced paw edema is
characterized by biphasic event with involvement of different inflammatory
mediators. In the first phase (during the first 2 h after carrageenan
injection), chemical mediators such as histamine and serotonin play role, while
in second phase (3 – 4 h after carrageenan injection). kinin and prostaglandins
are involved.11 As our
results revealed that administration of ethanolic extract during all phases of
inflammation, which is probably inhibition of different aspects and chemical
mediators of inflammation. The cotton-pellet granuloma is widely used to
evaluate the transudative and proliferative components of the chronic
inflammation.
The moist weight of the pellets correlates with
transude, the dry weight of the pellet correlates with the amount of
granulumatous tissues.12,13
Chronic inflammation occurs by means of
the development of proliferate cells These cells can be either spread or in
granuloma form. Non-steroidal anti-inflammatory drugs decrease the size of
granuloma which results from cellular reaction by inhibiting granulocyte
infiltration, preventing generation of collagen fibers and suppressing
mucopolysaccharides.14,15 The
alcoholic extract of Embelia tsjeriam - cottam showed significant
anti-inflammatory activity in cotton pellet induced granuloma and thus found to
be effective in chronic inflammatory conditions, which reflected its efficacy
in inhibiting the increase in the number of fibroblasts and synthesis of
collagen and mucopolysaccharides during granuloma tissue formation.
CONCLUSION:
The recent
studies of anti-inflammatory activity claims that the flavonoid promote
significant anti-inflammatory property.16 From the above studies it is quite apparent
that the alcoholic extract possesses significant anti-inflammatory activity
because of presence of flavonoid. The study justifies the use of Embelia tsjeriam - cottam in
inflammation as suggested in the folklore medicines
REFERENCES:
1.
Kirtikar, Basu B.D.(1984) Indian
Medicinal Plants. Vol-II 2nd ed. Singh B and singh MP, Dehraun,
1475-81.
2.
Khare, C P. Indian
Medicinal Plants. Springer US. 2008: 168
3.
Sharma PC, Yelne MB, DennisTJ (2002).
Database on medicinal plants used in Ayurveda, vol.5.central council for
research in Ayurveda and Siddha, govt. of India. New Delhi,478-99.
4.
Trease GE, Evans MC(1983) Text Book of Pharmacognosy,12th
edition Balliere,Tindall:London,343-353.
5.
OECD guidelines for Testing Chemicals, Guidelines 425, acute oral toxicity: Acute toxic toxic class
method. Paris: (1996).
6.
Winter CA, Risley EA, Nuss
GW(1962). Carrageenin induced oedemain the hind paw of the rat as an assay for
anti-inflammatory drug. Proc. Soc. Exptl. Biol. Med. 111:544-547
7.
Mohammed M.et al. Studies on the anti-inflammatory,antipyretic
and analgesic activities of Santonin.Japan J. Pharmacology,64:135-139
8.
Winter, C.A. and Porter,
C.C., Journal of American Pharmaceutical Association. 1957,46:515-519.
9.
Higgs GA,
Moncada S, Vane JR (1984). Eicosanoids in inflammation. Ann. Clin. Res. 16:
287-299.
10.
Vane JR
(1971). Inhibition of prostaglandin synthesis as a mechanism of action for
aspirin-like drugs. Nature New Biol.231-235.
11.
Hernandez PM,
Rabanal Gallego R (2002). Evaluation of the anti-inflammatory and analgesic
activity of Sideritis anariensis var. pannosa in mice J. Ethnopharmacol.
81: 43-47.
12.
Lowry OH,
Rosebrough NJ, Far AL, Randall RJ (1951). Protein measurement with the Folin
phenol reagent. J. Biol . Chem. 193: 265-275.
13.
Castro J,
Saseme H, Sussman H, Bullette P (1968). Diverse effect of SKF 52 and
antioxidants on CCL4 induced changes in liver microsomal P-450 content and
ethylmorphine metabolism. Life Sci.7: 129-136.
14.
Della Loggia
A, Tubaro A, Dri P, Zilli C, Del Negro P (1968). The role of flavonoids in the
anti-inflammatory activity of Chamomilla recutita. Clin. Biol. Res. 213:
481-486.
15.
Alcaraz MJ,
Jimenez MJ (1988). Flavonoide, an antiinflammatory agents. Fitoterapia 59:
25-38.
16.
Pandurangan A. Khosala RL, Hemalatha S.,Anti-inflammatory activity of an alkaloid
from Solanum trilobatum on acute and chronic inflammation models. Nat Prod Res. 2011 Mar 11:1-10.(PubMed).
Received on 12.08.2011
Accepted on 01.08.2011
© A&V Publication all right reserved
Research J. Pharmacology and
Pharmacodynamics. 3(5): Sept –Oct. 2011, 246-249